FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne-Mieke Vandamme

Research Profile

Living Beings

Disorders

HIV Infections

Concepts & Ideas

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Genome, Viral

Phenomena

Evolution, Molecular

Procedures

Co-author Network

Publications

TOP 3
Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
Jurgen Vercauteren; Maria João Aguas; Ricardo Camacho; Ana Patricia Carvalho; Luis Miguel Duque; Domitília Faria; Telo Faria; Kamal Mansinho; Susana Peres; Eugénio Teófilo; Kristof Theys; Emília Valadas; Anne-Mieke Vandamme; José Vera
The demise of multidrug-resistant HIV-1: the national time trend in Portugal.
Kristof Theys; Ana Abecasis; Anne-Mieke Vandamme
HIV-1 drug resistance: where do polymorphisms fit in?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne-Mieke Vandamme (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrea De Luca; Simona Di Giambenedetto; David Dunn; Iuri Fanti; Valeria Ghisetti; Rolf Kaiser; Mattia Prosperi; Anders Sönnerborg; Carlo Torti; David A M C van de Vijver; Kristel Van Laethem; Anne-Mieke Vandamme; Maurizio Zazzi; David Asboe; Loveleen Bansi; Ricardo Camacho; Francisco M Codoñer
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.
The Journal of infectious diseases 2013;207(8):1216-20.
2013: Jurgen Vercauteren; Maria João Aguas; Ricardo Camacho; Ana Patricia Carvalho; Luis Miguel Duque; Domitília Faria; Telo Faria; Kamal Mansinho; Susana Peres; Eugénio Teófilo; Kristof Theys; Emília Valadas; Anne-Mieke Vandamme; José Vera
The demise of multidrug-resistant HIV-1: the national time trend in Portugal.
The Journal of antimicrobial chemotherapy 2013;68(4):911-4.
2013: Kristof Theys; Ana Abecasis; Anne-Mieke Vandamme
HIV-1 drug resistance: where do polymorphisms fit in?
Future microbiology 2013;8(3):303-6.
2013: K Theys; C Torti; Anne-Mieke Vandamme; J Vercauteren; M Zazzi; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Z Grossman; E Schülter; Joke Snoeck; A Sönnerborg; D Struck; Ana Abecasis
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir.
Antimicrobial agents and chemotherapy 2013;57(2):1053-6.
2013: K Theys; Anne-Mieke Vandamme; J Vercauteren; Ana Abecasis; Ricardo Camacho; Joke Snoeck
Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.
The Journal of antimicrobial chemotherapy 2013;68(2):419-23.
2013: Jurgen Vercauteren; Maurizio Zazzi; Eric Van Wijngaerden; Anne-Mieke Vandamme; Gertjan Beheydt; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Anna Maria Geretti; Zehava Grossman; Stijn Imbrechts; Rolf Kaiser; Pieter Libin; Mattia Prosperi; Jean-Claude Schmit; Anders Sönnerborg; Carlo Torti; Kristel Van Laethem
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.
PloS one 2013;8(4):e61436.
2013: Fausta Mosha; Victor Muchunguzi; Peter Nsubuga; Raphael Z Sangeda; Eligius Lyamuya; Mecey Matee; Jurgen Vercauteren; Anne-Mieke Vandamme
Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.
BMC public health 2013;13():38.
2013: Joana Cavaco-Silva; Celso Cunha; Domitília Faria; Perpétua Gomes; Maria de Fátima Gonçalves; Emília Valadas; Kristel Van Laethem; Anne-Mieke Vandamme; Maria João Aleixo; Ricardo Jorge Camacho
Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.
The Journal of antimicrobial chemotherapy 2013;68(1):190-2.
2012: Vivian Kourí; Daniel Pérez; Jorge Pérez; Lissette Pérez; Yoeri Schrooten; Yudira Soto; Anne-Mieke Vandamme; Lore Vinken; Alina Álvarez; Delmis Álvarez; Yoan Alemán; Carlos Aragonés; Gertjan Beheydt; Jorge Campos; Consuelo Correa; Nathalie Dekeersmaeker; Carlos Fonseca; Stijn Imbrechts; Kristel Van Laethem
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2012;55(4):348-55.
2012: Andrea-Clemencia Pineda-Peña; Otto Sussmann; Kristel van Laethem; Anne-Mieke Vandamme; Jurgen Vercauteren; Diana-Carolina Bello; Arley Gómez-López
HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?
AIDS reviews 2012;14(4):256-67.
2012: João Dinis de Sousa; Anne-Mieke Vandamme; Carolina Alvarez; Viktor Müller
Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1.
Viruses 2012;4(10):1950-83.
2012: Ana Carolina Palma; Joke Snoeck; Ricardo Camacho; Kris Covens; Anne-Mieke Vandamme; Kristel Van Laethem
HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G.
The Journal of antimicrobial chemotherapy 2012;67(5):1075-9.
2012: Nuno R Faria; Maria F Gonçalves; Patrick Goubau; Ioannis Hodges-Mameletzis; Sabelle Jallow; Ricardo Camacho; João D de Sousa; Smit Erasmus; Stefania Paolucci; Danuta Pieniazek; Berta Rodés; Jean Ruelle; Joana C Silva; Vincent Soriano; Marc A Suchard; Nuno Taveira; Ana Treviño; Anne-Mieke Vandamme; Li Xu; Philippe Lemey
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.
The Journal of general virology 2012;93(Pt 4):889-99.
2012: Nuno R Faria; Ana Abecasis; Idalina Bonfim; Ricardo Camacho; Nicaise Ndembi; João D Sousa; Marc A Suchard; Anne-Mieke Vandamme; Philippe Lemey
Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2012;12(2):453-60.
2012: Thessika Hialla Almeida Araujo; Antonio Eduardo de Albuquerque-Junior; Koen Deforche; Dustin Edwards; Bernardo Galvao-Castro; Pieter Libin; Leandro Inacio Souza-Brito; Anne-Mieke Vandamme; Luiz Carlos Junior Alcantara
A public HTLV-1 molecular epidemiology database for sequence management and data mining.
PloS one 2012;7(9):e42123.
2012: Britta Moens; Christophe Pannecouque; Michael Talledo; Achiléa Bittencourt; Lourdes Farré; Bernardo Galvão-Castro; Eduardo Gotuzzo; Ricardo Khouri; Giovanni López; Anne-Mieke Vandamme; Johan Van Weyenbergh
Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.
Virology journal 2012;9():171.
2012: Britta Moens; Gilvanéia Silva-Santos; Michael Talledo; Anne-Mieke Vandamme; Carolina Alvarez; Ramon de Almeida Kruschewsky; Daniele Decanine; Bernardo Galvão-Castro; Eduardo Gotuzzo; Ricardo Khouri; Giovanni Lopez; Soraya Maria Menezes; Johan Van Weyenbergh
Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.
PLoS neglected tropical diseases 2012;6(7):e1729.
2011: Emmanouil Magiorkinis; Gkikas Magiorkinis; Akhteruzzaman Molla; Dimitrios Paraskevis; Tami Pilot-Matias; Kristel Van Laethem; Anne-Mieke Vandamme; Ricardo J Camacho; Maria G Detsika; Stijn Imbrechts; Marios Lazanas; Liangjun Lu; Angelos Hatzakis
Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility.
AIDS research and human retroviruses 2011;27(11):1223-9.
2011: Anne-Mieke Vandamme; Ricardo J Camacho; Francesca Ceccherini-Silberstein; Andreu de Luca; Lucia Palmisano; Dimitrios Paraskevis; Roger Paredes; Mario Poljak; Jean-Claude Schmit; Vincent Soriano; Hauke Walter; Anders Sönnerborg
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
AIDS reviews 2011;13(2):77-108.
2011: Maurizio Zazzi; R Kaiser; Anders Sönnerborg; Daniel Struck; A Altmann; M Prosperi; Michal Rosen-Zvi; A Petroczi; Y Peres; E Schülter; C A Boucher; F Brun-Vezinet; P R Harrigan; L Morris; M Obermeier; C-F Perno; P Phanuphak; D Pillay; R W Shafer; Anne-Mieke Vandamme; K van Laethem; A M J Wensing; Thomas Lengauer; F Incardona
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).
HIV medicine 2011;12(4):211-8.
2011: Ana B Abecasis; Anna Maria Geretti; Jan Albert; Lisa Power; Matthew Weait; Anne-Mieke Vandamme
Science in court: the myth of HIV fingerprinting.
The Lancet infectious diseases 2011;11(2):78-9.
2010: David A M C van de Vijver; Jori Symons; B Åsjö; M Bruckova; Ricardo Camacho; Andrzej Horban; M Linka; Marios Lazanas; C Loveday; E MacRae; C Nielsen; Dimitrios Paraskevis; M Poljak; Elisabeth Puchhammer-Stöckl; L Ruiz; J-C Schmit; G Stanczak; M Stanojevic; Anne-Mieke Vandamme; J Vercauteren; Maurizio Zazzi; Lee Bacheler; P Lecocq; Jorge Villacian; L B Jorgensen; Charles A B Boucher
HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.
Acta dermatovenerologica Alpina, Panonica, et Adriatica 2010;19(4):3-9.
2010: K Theys; Koen Deforche; P Libin; Ricardo Camacho; Kristel Van Laethem; Anne-Mieke Vandamme
Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine.
The Journal of general virology 2010;91(Pt 8):1898-908.
2010: Kris Covens; Sarah Megens; Nathalie Dekeersmaeker; Kabamba Kabeya; Jan Balzarini; Stéphane De Wit; Anne-Mieke Vandamme; Kristel Van Laethem
The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide.
Antiviral research 2010;86(3):253-60.
2010: Ana Abecasis; Yunpeng Wang; Pieter Libin; Stijn Imbrechts; Tulio De Oliveira; Ricardo Camacho; Anne-Mieke Vandamme
Comparative performance of the REGA subtyping tool version 2 versus version 1.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2010;10(3):380-5.
2010: Ana Carolina Palma; Ana Barroso Abecasis; Jurgen Vercauteren; Ana Patricia Carvalho; Joaquim Cabanas; Anne-Mieke Vandamme; Ricardo Jorge Camacho
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2010;10(3):373-9.
2010: Lotte Coelmont; Xavier Hanoulle; Udayan Chatterji; Carola Berger; Joke Snoeck; Michael Bobardt; Precious Lim; Inge Vliegen; Jan Paeshuyse; Grégoire Vuagniaux; Anne-Mieke Vandamme; Ralf Bartenschlager; Philippe Gallay; Guy Lippens; Johan Neyts
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.
PloS one 2010;5(10):e13687.
2010: Mattia C F Prosperi; Michal Rosen-Zvi; André Altmann; Maurizio Zazzi; Simona Di Giambenedetto; Rolf Kaiser; Eugen Schülter; Daniel Struck; Peter Sloot; David A van de Vijver; Anne-Mieke Vandamme; Anders Sönnerborg
Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.
PloS one 2010;5(10):e13753.
2010: Kristof Theys; Koen Deforche; Gertjan Beheydt; Yves Moreau; Kristel Van Laethem; Philippe Lemey; Ricardo Camacho; Soo-Yon Rhee; Robert W Shafer; Eric Van Wijngaerden; Anne-Mieke Vandamme
Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape.
BMC bioinformatics 2010;11():409.
2010: Dineke Frentz; Charles A B Boucher; Matthias Assel; Andrea De Luca; Massimiliano Fabbiani; Francesca Incardona; Pieter Libin; Nino Manca; Viktor Müller; Breanndán O Nualláin; Roger Paredes; Mattia Prosperi; Eugenia Quiros-Roldan; Lidia Ruiz; Peter M A Sloot; Carlo Torti; Anne-Mieke Vandamme; Kristel Van Laethem; Maurizio Zazzi; David A M C van de Vijver
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.
PloS one 2010;5(7):e11505.
2010: Victoria L Demetriou; David A M C van de Vijver; Ioanna Kousiappa; Claudia Balotta; Bonaventura Clotet; Zehava Grossman; Louise B Jørgensen; Snjezana Z Lepej; Itzchak Levy; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Francois Roman; Lidia Ruiz; Jean-Claude Schmidt; Anne-Mieke Vandamme; Kristel Van Laethem; Jurgen Vercauteren; Leondios G Kostrikis
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe.
PloS one 2010;5(6):e10976.
2010: João Dinis de Sousa; Viktor Müller; Philippe Lemey; Anne-Mieke Vandamme
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains.
PloS one 2010;5(4):e9936.
2009: Ana B Abecasis; Anne-Mieke Vandamme; Philippe Lemey
Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution.
Journal of virology 2009;83(24):12917-24.
2009: Britta Moens; Giovanni López; Vanessa Adaui; Elsa González; Lien Kerremans; Daniel Clark; Kristien Verdonck; Eduardo Gotuzzo; Guido Vanham; Olivier Cassar; Antoine Gessain; Anne-Mieke Vandamme; Sonia Van Dooren
Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.
Journal of clinical microbiology 2009;47(11):3682-91.
2009: Soo-Yon Rhee; W Jeffrey Fessel; Tommy F Liu; Natalia M Marlowe; Charles M Rowland; Richard Rode; Anne-Mieke Vandamme; Kristel Van Laethem; Françoise Brun Vezinet; Vincent Calvez; Jonathan Taylor; Leo Hurley; Michael Horberg; Robert W Shafer
Predictive value of HIV-1 genotypic resistance test interpretation algorithms.
The Journal of infectious diseases 2009;200(3):453-63.
2009: Luiz Carlos Junior Alcantara; Sharon Cassol; Pieter Libin; Koen Deforche; Oliver G Pybus; Marc Van Ranst; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Tulio de Oliveira
A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences.
Nucleic acids research 2009;37(Web Server issue):W634-42.
2009: Kris Covens; Nathalie Dekeersmaeker; Yoeri Schrooten; Jan Weber; Dominique Schols; Miguel E Quiñones-Mateu; Anne-Mieke Vandamme; Kristel Van Laethem
Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
Journal of clinical microbiology 2009;47(7):2232-42.
2009: Anne-Mieke Vandamme
Bioinformatics tools for the investigation of emerging and re-emerging infectious diseases. Introduction.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2009;9(4):671.
2009: Kristof Theys; Jurgen Vercauteren; Ana Abecasis; Pieter Libin; Koen Deforche; Anne-Mieke Vandamme; Ricardo Camacho
The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2009;9(4):683-8.
2009: Kris Covens; Kabamba Kabeya; Yoeri Schrooten; Nathalie Dekeersmaeker; Eric Van Wijngaerden; Anne-Mieke Vandamme; Stéphane De Wit; Kristel Van Laethem
Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;44(4):325-8.
2009: Kristien Verdonck; Elsa González; Fernando Maldonado; Doris Agapito; Sonia Van Dooren; Anne-Mieke Vandamme; Alfonso Silva-Santisteban; Guido Vanham; Daniel Clark; Eduardo Gotuzzo
Comparison of three ELISAs for the routine diagnosis of human T-lymphotropic virus infection in a high-prevalence setting in Peru.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2009;103(4):420-2.
2009: André F A Santos; Ana Abecasis; Anne-Mieke Vandamme; Ricardo Camacho; Marcelo A Soares
Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
The Journal of antimicrobial chemotherapy 2009;63(3):593-9.
2009: Matthias Assel; David van de Vijver; Pieter Libin; Kristof Theys; Daniel Harezlak; Breanndán O Nualláin; Piotr Nowakowski; Marian Bubak; Anne-Mieke Vandamme; Stijn Imbrechts; Raphael Sangeda; Tao Jiang; Dineke Frentz; P M A Sloot
A collaborative environment allowing clinical investigations on integrated biomedical databases.
Studies in health technology and informatics 2009;147():51-61.
2009: Mattia C F Prosperi; Andre Altmann; Michal Rosen-Zvi; Ehud Aharoni; Gábor Borgulya; Fulop Bazso; Anders Sönnerborg; Eugen Schülter; Daniel Struck; Giovanni Ulivi; Anne-Mieke Vandamme; Jurgen Vercauteren; Maurizio Zazzi
Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
Antiviral therapy 2009;14(3):433-42.
2009: Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis; Angelos Hatzakis; Annemarie Mj Wensing; David A van de Vijver; Jan Albert; Guiseppe Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Suzie Coughlan; Dominique Costagliola; Andrea De Luca; Carmen de Mendoza; Inge Derdelinckx; Zehava Grossman; Osama Hamouda; Im Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh Macrae; I Maljkovic-Berry; Laurence Meyer; Claus Nielsen; Eline Lm Op de Coul; Vidar Ormaasen; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika O Salminen; Jean-Claude Schmit; Rob Schuurman; Vincent Soriano; J Stanczak; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; M Violin; Sabine Yerly; Maurizio Zazzi; Charles A Boucher; Anne-Mieke Vandamme
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.
Retrovirology 2009;6():49.
2009: Diane E Bennett; Ricardo J Camacho; dan otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
PloS one 2009;4(3):e4724.
2009: Jan Clement; Jurgen Vercauteren; Willem W Verstraeten; Geneviève Ducoffre; José M Barrios; Anne-Mieke Vandamme; Piet Maes; Marc Van Ranst
Relating increasing hantavirus incidences to the changing climate: the mast connection.
International journal of health geographics 2009;8():1.
2008: Kristel Van Laethem; Yoeri Schrooten; Kris Covens; Nathalie Dekeersmaeker; Paul De Munter; Eric Van Wijngaerden; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
Journal of virological methods 2008;153(2):176-81.
2008: Koen Deforche; Ricardo Camacho; Zehave Grossman; Marcelo A Soares; Kristel Van Laethem; David A Katzenstein; P Richard Harrigan; Rami Kantor; Robert Shafer; Anne-Mieke Vandamme
Bayesian network analyses of resistance pathways against efavirenz and nevirapine.
AIDS (London, England) 2008;22(16):2107-15.
2008: Ann E Deschamps; Sabina De Geest; Anne-Mieke Vandamme; Herman Bobbaers; Willy E Peetermans; Eric Van Wijngaerden
Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards.
AIDS patient care and STDs 2008;22(9):735-43.
2008: Jean-Marie Zimmer; François Roman; Christine Lambert; Abel Jonckheer; Ana Vazquez; Jean-Marc Plesséria; Jean-Yves Servais; Kris Covens; Jan Weber; Kristel Van Laethem; Jean-Claude Schmit; Anne-Mieke Vandamme; Miguel E Quinones-Mateu; Marc De Maeyer
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):255-62.
2008: Luis M F Gonzalez; André F A Santos; Ana Abecasis; Kristel Van Laethem; Esmeralda A J M Soares; Koen Deforche; Amilcar Tanuri; Ricardo Camacho; Anne-Mieke Vandamme; Marcelo A Soares
Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
The Journal of antimicrobial chemotherapy 2008;61(6):1201-4.
2008: Catharina Matheï; Sonia Van Dooren; Philippe Lemey; Pierre Van Damme; Frank Buntinx; Anne-Mieke Vandamme
The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium.
Journal of viral hepatitis 2008;15(6):399-408.
2008: Kristof Theys; Anne-Mieke Vandamme
Understanding the changing prevalence of K65R.
AIDS reviews 2008;10(2):125.
2008: Jurgen Vercauteren; Inge Derdelinckx; André Sasse; Marleen Bogaert; Helga Ceunen; Ann De Roo; Stephane De Wit; Koen Deforche; Fedoua Echahidi; Katrien Fransen; Jean-Christophe Goffard; Patrick Goubau; Elodie Goudeseune; Jean-Cyr Yombi; Patrick Lacor; Corinne Liesnard; Michel Moutschen; Denis Pierard; Roeland Rens; Yoeri Schrooten; Dolores Vaira; Annelies van den Heuvel; Bea van der Gucht; Marc Van Ranst; Eric van Wijngaerden; Bernard Vandercam; Marc Vekemans; Chris Verhofstede; Nathan Clumeck; Anne-Mieke Vandamme; Kristel van Laethem
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.
AIDS research and human retroviruses 2008;24(3):355-62.
2008: Lourdes Farre; Maria de Fátima Paim de Oliveira; Janeusa Primo; Anne-Mieke Vandamme; Johan Van Weyenbergh; Achiléa L Bittencourt
Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):440-2.
2008: Koen Deforche; Alessandro Cozzi-Lepri; Kristof Theys; Bonaventura Clotet; Ricardo Camacho; Jesper Kjaer; Kristel Van Laethem; Andrew Phillips; Yves Moreau; Jens D Lundgren; Anne-Mieke Vandamme
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
Antiviral therapy 2008;13(3):399-407.
2008: P M A Sloot; Peter Coveney; Marian T Bubak; Anne-Mieke Vandamme; Breanndán O Nualláin; David van de Vijver; Charles A B Boucher
Multi-science decision support for HIV drug resistance treatment.
Studies in health technology and informatics 2008;138():188-98.
2008: Jurgen Vercauteren; Koen Deforche; Kristof Theys; Michiel Debruyne; Luis Miguel Duque; Susana Peres; Ana Patrícia Carvalho; Kamal Mansinho; Anne-Mieke Vandamme; Ricardo Camacho
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal.
Retrovirology 2008;5():12.
2008: Yung Shwen Ho; Ana Abecasis; Kristof Theys; Koen Deforche; Dominic E Dwyer; Michael Charleston; Anne-Mieke Vandamme; Nitin K Saksena
HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments.
Virology journal 2008;5():14.
2008: Teresa C Arrais; Sonia Van Dooren; Anne-Mieke Vandamme; Christian Brechot; Francois Rimlinger; Antonio Eduardo B Silva; Renata M Perez; Maria Lucia G Ferraz; Valérie Thiers
Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy--relapse or re-infection?
Journal of medical virology 2008;80(1):80-6.
2008: Koen Deforche; Ricardo Camacho; Kristel Van Laethem; Philippe Lemey; Andrew Rambaut; Yves Moreau; Anne-Mieke Vandamme
Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.
Bioinformatics (Oxford, England) 2008;24(1):34-41.
2008: L Farre; Achiléa L Bittencourt; G Silva-Santos; A Almeida; A C Silva; D Decanine; George Soares; Luiz C J Alcantara; Sonia Van Dooren; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Journal of leukocyte biology 2008;83(1):220-2.
2007: Robert James Gifford; Tulio De Oliveira; Andrew Rambaut; Oliver G Pybus; David Dunn; Anne-Mieke Vandamme; Kellam Paul; Deenan Pillay
Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1.
Journal of virology 2007;81(23):13050-6.
2007: Eduardo Gotuzzo; Joel Moody; Kristien Verdonck; Miguel M Cabada; Elsa González; Sonia Van Dooren; Anne-Mieke Vandamme; Angélica Terashima; Sten Vermund
Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis.
Revista panamericana de salud pública = Pan American journal of public health 2007;22(4):223-30.
2007: Koen Deforche; Ricardo Camacho; Kristel Van Laethem; Beth Shapiro; Yves Moreau; Andrew Rambaut; Anne-Mieke Vandamme; Philippe Lemey
Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo.
Journal of computational biology : a journal of computational molecular cell biology 2007;14(8):1105-14.
2007: E J Bernard; Y Azad; Anne-Mieke Vandamme; M Weait; A M Geretti
HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission.
HIV medicine 2007;8(6):382-7.
2007: Kristel Van Laethem; Christophe Pannecouque; Anne-Mieke Vandamme
Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2007;7(5):600-3.
2007: Ana Abecasis; Philippe Lemey; Nicole Vidal; Tulio De Oliveira; Martine Peeters; Ricardo Camacho; Beth Shapiro; Andrew Rambaut; Anne-Mieke Vandamme
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.
Journal of virology 2007;81(16):8543-51.
2007: Achiléa L Bittencourt; Helenemarie S Barbosa; Cristiane Requião; Aline Clara da Silva; Anne-Mieke Vandamme; Johan Van Weyenbergh; Lourdes Farré
Adult T-cell leukemia/lymphoma with a mixed CD4+ and CD8+ phenotype and indolent course.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2480-2.
2007: K Deforche; R Camacho; Z Grossman; T Silander; M A Soares; Y Moreau; R W Shafer; K Van Laethem; A P Carvalho; B Wynhoven; P Cane; J Snoeck; J Clarke; S Sirivichayakul; K Ariyoshi; A Holguin; H Rudich; R Rodrigues; M B Bouzas; Pedro Cahn; Luis Brigido; V Soriano; Wataru Sugiura; P Phanuphak; L Morris; J Weber; D Pillay; A Tanuri; P R Harrigan; J M Shapiro; D A Katzenstein; R Kantor; Anne-Mieke Vandamme
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2007;7(3):382-90.
2007: Sonia Van Dooren; Ernst J Verschoor; Zahra Fagrouch; Anne-Mieke Vandamme
Phylogeny of primate T lymphotropic virus type 1 (PTLV-1) including various new Asian and African non-human primate strains.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2007;7(3):374-81.
2007: Kristel Van Laethem; Paul De Munter; Yoeri Schrooten; Rene Verbesselt; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;39(1):43-7.
2007: Augusto Cesar Andrade Mota; Sonia Van Dooren; Flora Maria de Campos Fernandes; Sergio Araujo Pereira; Artur Trancoso Lopo Queiroz; Viviana Olavarria Gallazzi; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Luiz C J Alcantara
The close relationship between South African and Latin American HTLV type 1 strains corroborated in a molecular epidemiological study of the HTLV type 1 isolates from a blood donor cohort.
AIDS research and human retroviruses 2007;23(4):503-7.
2007: Kristien Verdonck; Elsa González; Sonia Van Dooren; Anne-Mieke Vandamme; Guido Vanham; Eduardo Gotuzzo
Human T-lymphotropic virus 1: recent knowledge about an ancient infection.
The Lancet infectious diseases 2007;7(4):266-81.
2007: Ricardo Camacho; Anne-Mieke Vandamme
Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation.
Current opinion in HIV and AIDS 2007;2(2):123-9.
2007: Sonia Resik; Philippe Lemey; Li-Hua Ping; Vivian Kouri; Jose Joanes; Jorge Pérez; Anne-Mieke Vandamme; Ronald Swanstrom
Limitations to contact tracing and phylogenetic analysis in establishing HIV type 1 transmission networks in Cuba.
AIDS research and human retroviruses 2007;23(3):347-56.
2006: Koen Deforche; T Silander; Ricardo Camacho; Z Grossman; M A Soares; Kristel Van Laethem; Rami Kantor; Yves Moreau; Anne-Mieke Vandamme
Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance.
Bioinformatics (Oxford, England) 2006;22(24):2975-9.
2006: Ann E Deschamps; Eric Van Wijngaerden; Kris Denhaerynck; Sabina De Geest; Anne-Mieke Vandamme
Use of electronic monitoring induces a 40-day intervention effect in HIV patients.
Journal of acquired immune deficiency syndromes (1999) 2006;43(2):247-8.
2006: Jurgen Vercauteren; Anne-Mieke Vandamme
Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
Antiviral research 2006;71(2-3):335-42.
2006: Robert James Gifford; Tulio De Oliveira; Andrew Rambaut; Richard E Myers; Catherine V Gale; David Dunn; Robert Shafer; Anne-Mieke Vandamme; Kellam Paul; Deenan Pillay
Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity.
AIDS (London, England) 2006;20(11):1521-9.
2006: Dunja Z Babic; Mojca Zelnikar; Katja Seme; Anne-Mieke Vandamme; Joke Snoeck; Janez Tomazic; Ludvik Vidmar; Primoz Karner; Mario Poljak
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Virus research 2006;118(1-2):156-63.
2006: Simon J Potter; Philippe Lemey; Wayne B Dyer; John Sullivan; Choo Beng Chew; Anne-Mieke Vandamme; Dominic E Dwyer; Nitin K Saksena
Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART.
Virology 2006;348(1):35-46.
2006: David A van de Vijver; Annemarie M J Wensing; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L M Op de Coul; Vidar Ormaasen; Dimitrios Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A B Boucher
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.
Journal of acquired immune deficiency syndromes (1999) 2006;41(3):352-60.
2006: Kristel Van Laethem; Yoeri Schrooten; Sarah Dedecker; Lies Van Heeswijck; Koen Deforche; Eric Van Wijngaerden; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
Journal of virological methods 2006;132(1-2):181-6.
2006: Joke Snoeck; Rami Kantor; Robert W Shafer; Kristel Van Laethem; Koen Deforche; Ana Patricia Carvalho; Brian Wynhoven; Marcelo A Soares; Patricia Cane; John Clarke; Candice Pillay; Sunee Sirivichayakul; Koya Ariyoshi; Africa Holguin; Hagit Rudich; Rosangela Rodrigues; Maria Belen Bouzas; Françoise Brun-Vézinet; Caroline Reid; Pedro Cahn; Luis Brigido; Zehava Grossman; Vincent Soriano; Wataru Sugiura; Praphan Phanuphak; Lynn Morris; Jonathan Weber; Deenan Pillay; Amilcar Tanuri; Richard P Harrigan; Ricardo Camacho; Jonathan M Schapiro; David Katzenstein; Anne-Mieke Vandamme
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.
Antimicrobial agents and chemotherapy 2006;50(2):694-701.
2006: Laurence Vergne; Joke Snoeck; Avelin F Aghokeng; Bart Maes; Diane Valea; Eric Delaporte; Anne-Mieke Vandamme; Martine Peeters; Kristel Van Laethem
Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients.
FEMS immunology and medical microbiology 2006;46(1):53-62.
2006: Ana Abecasis; Koen Deforche; Lee Bacheler; Paula McKenna; Ana Patrícia Carvalho; Perpétua Gomes; Anne-Mieke Vandamme; Ricardo Camacho
Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.
Antiviral therapy 2006;11(5):581-9.
2006: Kristel Van Laethem; Anne-Mieke Vandamme
Interpreting resistance data for HIV-1 therapy management--know the limitations.
AIDS reviews 2006;8(1):37-43.
2005: Ana Abecasis; Koen Deforche; Joke Snoeck; Lee Bacheler; Paula McKenna; Ana Patrícia Carvalho; Perpétua Gomes; Ricardo Camacho; Anne-Mieke Vandamme
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.
AIDS (London, England) 2005;19(16):1799-806.
2005: Philippe Lemey; Sonia Van Dooren; Kristel Van Laethem; Yoeri Schrooten; Inge Derdelinckx; Patrick Goubau; Françoise Brun-Vézinet; Dolores Vaira; Anne-Mieke Vandamme
Molecular testing of multiple HIV-1 transmissions in a criminal case.
AIDS (London, England) 2005;19(15):1649-58.
2005: Tulio De Oliveira; Koen Deforche; Sharon Cassol; Mika Salminen; Dimitrios Paraskevis; Chris Seebregts; Joe Snoeck; Estrelita Janse van Rensburg; Jori Symons; David A van de Vijver; Charles A B Boucher; Ricardo Camacho; Anne-Mieke Vandamme
An automated genotyping system for analysis of HIV-1 and other microbial sequences.
Bioinformatics (Oxford, England) 2005;21(19):3797-800.
2005: Philippe Lemey; Anne-Mieke Vandamme
Exploring full-genome sequences for phylogenetic support of HIV-1 transmission events.
AIDS (London, England) 2005;19(14):1551-2.
2005: Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitrios Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.
The Journal of infectious diseases 2005;192(6):958-66.
2005: Wouter Meersseman; Kristel Van Laethem; Katrien Lagrou; Guido Wilms; Raf Sciot; Marc Van Ranst; Anne-Mieke Vandamme; Eric Van Wijngaerden
Fatal brain necrosis in primary HIV infection.
Lancet 2005;366(9488):866.
2005: Philippe Lemey; Inge Derdelinckx; Andrew Rambaut; Kristel Van Laethem; Stephanie Dumont; Steve Vermeulen; Eric Van Wijngaerden; Anne-Mieke Vandamme
Molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain.
Journal of virology 2005;79(18):11981-9.
2005: Joke Snoeck; C Riva; K Steegen; Yoeri Schrooten; Bart Maes; Laurence Vergne; Kristel Van Laethem; Martine Peeters; Anne-Mieke Vandamme
Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes.
Journal of virological methods 2005;128(1-2):47-53.
2005: Kalina T Zlateva; Philippe Lemey; Elien Moës; Anne-Mieke Vandamme; Marc Van Ranst
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.
Journal of virology 2005;79(14):9157-67.
2005: Sonia Van Dooren; Laurent Meertens; Philippe Lemey; Antoine Gessain; Anne-Mieke Vandamme
Full-genome analysis of a highly divergent simian T-cell lymphotropic virus type 1 strain in Macaca arctoides.
The Journal of general virology 2005;86(Pt 7):1953-9.
2005: Leen Vijgen; Els Keyaerts; Philippe Lemey; Elien Moës; Sandra Li; Anne-Mieke Vandamme; Marc Van Ranst
Circulation of genetically distinct contemporary human coronavirus OC43 strains.
Virology 2005;337(1):85-92.
2005: Meriet Mikhail; Bin Wang; Philippe Lemey; Brenda Beckholdt; Anne-Mieke Vandamme; Michael John Gill; Nitin K Saksena
Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS.
AIDS research and human retroviruses 2005;21(6):575-9.
2005: Marco Salemi; Tulio De Oliveira; Marcelo A Soares; Oliver G Pybus; Ana T Dumans; Anne-Mieke Vandamme; Amilcar Tanuri; Sharon Cassol; Walter M Fitch
Different epidemic potentials of the HIV-1B and C subtypes.
Journal of molecular evolution 2005;60(5):598-605.
2005: Rami Kantor; David A Katzenstein; Brad Efron; Ana Patricia Carvalho; Brian Wynhoven; Patricia Cane; John Clarke; Sunee Sirivichayakul; Marcelo A Soares; Joke Snoeck; Candice Pillay; Hagit Rudich; Rosangela Rodrigues; Africa Holguin; Koya Ariyoshi; Maria Belen Bouzas; Pedro Cahn; Wataru Sugiura; Vincent Soriano; Luis Brigido; Zehava Grossman; Lynn Morris; Anne-Mieke Vandamme; Amilcar Tanuri; Praphan Phanuphak; Jonathan N Weber; Deenan Pillay; P Richard Harrigan; Ricardo Camacho; Jonathan M Schapiro; Robert W Shafer
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
PLoS medicine 2005;2(4):e112.
2005: Philippe Lemey; Oliver G Pybus; Sonia Van Dooren; Anne-Mieke Vandamme
A Bayesian statistical analysis of human T-cell lymphotropic virus evolutionary rates.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):291-8.
2005: Ana Abecasis; Dimitrios Paraskevis; M Epalanga; M Fonseca; F Burity; J Bartolomeu; Ana Patrícia Carvalho; Perpétua Gomes; Anne-Mieke Vandamme; Ricardo Camacho
HIV-1 genetic variants circulation in the North of Angola.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):231-7.
2005: Gkikas Magiorkinis; Dimitrios Paraskevis; Emmanouil Magiorkinis; Anne-Mieke Vandamme; Angelos Hatzakis
Re-analysis of 34 full-length HIV-1 intersubtype recombinant sequences.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):225-9.
2005: Dimitrios Paraskevis; Koen Deforche; Ana Abecasis; Ricardo Camacho; Anne-Mieke Vandamme
Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):219-24.
2005: Philippe Lemey; Sonia Van Dooren; Anne-Mieke Vandamme
Evolutionary dynamics of human retroviruses investigated through full-genome scanning.
Molecular biology and evolution 2005;22(4):942-51.
2005: Dimitrios Paraskevis; Koen Deforche; Philippe Lemey; Gkikas Magiorkinis; A Hatzakis; Anne-Mieke Vandamme
SlidingBayes: exploring recombination using a sliding window approach based on Bayesian phylogenetic inference.
Bioinformatics (Oxford, England) 2005;21(7):1274-5.
2005: Leen Vijgen; Els Keyaerts; Elien Moës; Inge Thoelen; Elke Wollants; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event.
Journal of virology 2005;79(3):1595-604.
2005: Anke Hantson; Valery Fikkert; Barbara Van Remoortel; Christophe Pannecouque; Peter Cherepanov; Barry Matthews; George Holan; Erik De Clercq; Anne-Mieke Vandamme; zeger debyser; Myriam Witvrouw
Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology.
Antiviral chemistry & chemotherapy 2005;16(4):253-66.
2005: Meriet Mikhail; Bin Wang; Philippe Lemey; Brenda Beckthold; Anne-Mieke Vandamme; Michael John Gill; Nitin K Saksena
Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort.
Retrovirology 2005;2():41.
2005: Kristel Van Laethem; Yoeri Schrooten; Philippe Lemey; Eric Van Wijngaerden; Stéphane De Wit; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.
Journal of virological methods 2005;123(1):25-34.
2004: Inge Derdelinckx; Kristel Van Laethem; Bart Maes; Yoeri Schrooten; Stéphane De Wit; Eric Florence; Katrien Fransen; Sergio García Ribas; Denise Marissens; Michel Moutschen; Dolores Vaira; Georges Zissis; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1664-6.
2004: Anne-Mieke Vandamme; Anders Sönnerborg; M Ait-Khaled; J Albert; B Asjo; Lee Bacheler; D Banhegyi; C Boucher; F Brun-Vézinet; R Camacho; P Clevenbergh; N Clumeck; N Dedes; Andrea De Luca; H W Doerr; J L Faudon; G Gatti; J Gerstoft; W W Hall; A Hatzakis; N Hellmann; A Horban; J D Lundgren; D Kempf; M Miller; V Miller; T W Myers; C Nielsen; M Opravil; L Palmisano; C F Perno; A Phillips; D Pillay; T Pumarola; L Ruiz; M Salminen; J Schapiro; B Schmidt; Jean-Claude Schmit; R Schuurman; E Shulse; V Soriano; S Staszewski; STEFANO VELLA; M Youle; R Ziermann; L Perrin
Updated European recommendations for the clinical use of HIV drug resistance testing.
Antiviral therapy 2004;9(6):829-48.
2004: Rainer Ziermann; Linda Celis; Inge Derdelinckx; Christine Lambert; Jürgen Veeck; Maria Gabriella Rizzo; Bart Vanderborght; Georges Zissis; Nathan Clumeck; Katrien Fransen; Dolores Vaira; David Hendricks; Kristel Van Laethem; Anne-Mieke Vandamme; Jean-Claude Schmit; Heribert Knechten; Andrea De Luca; joost louwagie; Pascale Segers; Kristel De Boeck; Hans Pottel; Annelies De Brauwer; Frank Hulstaert
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31 Suppl 1():S7-15.
2004: Dimitrios Paraskevis; Emmanouil Magiorkinis; Gkikas Magiorkinis; Vassilios G Kiosses; Philippe Lemey; Anne-Mieke Vandamme; Andrew Rambaut; Angelos Hatzakis
Phylogenetic reconstruction of a known HIV-1 CRF04_cpx transmission network using maximum likelihood and Bayesian methods.
Journal of molecular evolution 2004;59(5):709-17.
2004: Ann E Deschamps; Veerle D E Graeve; Eric Van Wijngaerden; Veerle De Saar; Anne-Mieke Vandamme; Kristien Van Vaerenbergh; Helga Ceunen; Herman Bobbaers; Willy E Peetermans; Peter J de Vleeschouwer; Sabina De Geest
Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System.
AIDS patient care and STDs 2004;18(11):644-57.
2004: Gkikas Magiorkinis; Emmanouil Magiorkinis; Dimitrios Paraskevis; Anne-Mieke Vandamme; Marc Van Ranst; V Moulton; Angelos Hatzakis
Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions.
Journal of medical virology 2004;74(3):369-72.
2004: Eduardo Gotuzzo; J Cabrera; L Deza; Kristien Verdonck; Anne-Mieke Vandamme; R Cairampoma; D Vizcarra; Miguel M Cabada; Guillermo Narvarte; C De las Casas
Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):939-44.
2004: Jan Balzarini; Kristel Van Laethem; Sigrid Hatse; Kurt Vermeire; Erik De Clercq; Willy J Peumans; Els Van Damme; Anne-Mieke Vandamme; Anders Bölmstedt; Dominique Schols; Anders Böhlmstedt
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
Journal of virology 2004;78(19):10617-27.
2004: Simon J Potter; Philippe Lemey; Guillaume Achaz; Choo Beng Chew; Anne-Mieke Vandamme; Dominic E Dwyer; Nitin K Saksena
HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy.
Journal of leukocyte biology 2004;76(3):562-70.
2004: Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Alexei J Drummond; David L Robertson; Pierre Roques; Michael Worobey; Anne-Mieke Vandamme
The molecular population genetics of HIV-1 group O.
Genetics 2004;167(3):1059-68.
2004: Tulio De Oliveira; Marco Salemi; Michelle Gordon; Anne-Mieke Vandamme; Estrelita Janse van Rensburg; Susan Engelbrecht; Hoosen M Coovadia; Sharon Cassol
Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?
Genetics 2004;167(3):1047-58.
2004: Bart Maes; Yoeri Schrooten; Joke Snoeck; Inge Derdelinckx; Marc Van Ranst; Anne-Mieke Vandamme; Kristel Van Laethem
Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.
Journal of virological methods 2004;119(1):45-9.
2004: Valerie Courgnaud; Sonia Van Dooren; Florian Liegeois; Xavier Pourrut; Bernadette Abela; Severin Loul; Eitel Mpoudi-Ngole; Anne-Mieke Vandamme; Eric Delaporte; Martine Peeters
Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis).
Journal of virology 2004;78(9):4700-9.
2004: Kalina T Zlateva; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein.
Journal of virology 2004;78(9):4675-83.
2004: Joke Snoeck; Kristel Van Laethem; Philippe Hermans; Eric Van Wijngaerden; Inge Derdelinckx; Yoeri Schrooten; David A M C van de Vijver; Stéphane De Wit; Nathan Clumeck; Anne-Mieke Vandamme
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):279-85.
2004: Inge Thoelen; Elien Moës; Philippe Lemey; Sara Mostmans; Elke Wollants; A Michael Lindberg; Anne-Mieke Vandamme; Marc Van Ranst
Analysis of the serotype and genotype correlation of VP1 and the 5' noncoding region in an epidemiological survey of the human enterovirus B species.
Journal of clinical microbiology 2004;42(3):963-71.
2004: Sonia Van Dooren; Oliver G Pybus; Marco Salemi; HF Liu; Patrick Goubau; Carlos Remondegui; A Talarmin; Eduardo Gotuzzo; Luiz C J Alcantara; Bernardo Galvão-Castro; Anne-Mieke Vandamme
The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains.
Molecular biology and evolution 2004;21(3):603-11.
2004: Sonia Van Dooren; Vedapuri Shanmugam; Vinod Bhullar; Bharat Parekh; Anne-Mieke Vandamme; Walid Heneine; William Switzer
Identification in gelada baboons (Theropithecus gelada) of a distinct simian T-cell lymphotropic virus type 3 with a broad range of Western blot reactivity.
The Journal of general virology 2004;85(Pt 2):507-19.
2003: Dimitrios Paraskevis; Philippe Lemey; Marco Salemi; M Suchard; Y Van De Peer; Anne-Mieke Vandamme
Analysis of the evolutionary relationships of HIV-1 and SIVcpz sequences using bayesian inference: implications for the origin of HIV-1.
Molecular biology and evolution 2003;20(12):1986-96.
2003: Philippe Lemey; Marco Salemi; Bin Wang; Margaret Duffy; William H Hall; Nitin K Saksena; Anne-Mieke Vandamme
Site stripping based on likelihood ratio reduction is a useful tool to evaluate the impact of non-clock-like behavior on viral phylogenetic reconstructions.
FEMS immunology and medical microbiology 2003;39(2):125-32.
2003: Inge Derdelinckx; Kristel Van Laethem; Bart Maes; Yoeri Schrooten; Kirsten De Schouwer; Stéphane De Wit; Katrien Fransen; Sergio García Ribas; Michel Moutschen; Dolores Vaira; Georges Zissis; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.
FEMS immunology and medical microbiology 2003;39(2):119-24.
2003: Anne-Mieke Vandamme
Viral evolution and molecular epidemiology--evolving viruses and evolving analysis techniques.
FEMS immunology and medical microbiology 2003;39(2):95-6.
2003: Katharina Wolf; Hauke Walter; Niko Beerenwinkel; Wilco Keulen; Rolf Kaiser; Daniel Hoffmann; Thomas Lengauer; Joachim Selbig; Anne-Mieke Vandamme; Klaus Korn; Barbara Schmidt
Tenofovir resistance and resensitization.
Antimicrobial agents and chemotherapy 2003;47(11):3478-84.
2003: Gkikas Magiorkinis; Dimitrios Paraskevis; Anne-Mieke Vandamme; Emmanouil Magiorkinis; Vana Sypsa; Angelos Hatzakis
In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity.
The Journal of general virology 2003;84(Pt 10):2715-22.
2003: Luiz Carlos Alcantara Jr; Sonia Van Dooren; Marilda Souza Gonçalves; Simone Kashima; Maria Cecília Costa; Fred Luciano Neves Santos; Achiléa L Bittencourt; Inês Dourado; Antonio Andrade Filho; Dimas Tadeu Covas; Anne-Mieke Vandamme; Bernardo Galvão-Castro
Globin haplotypes of human T-cell lymphotropic virus type I-infected individuals in Salvador, Bahia, Brazil, suggest a post-Columbian African origin of this virus.
Journal of acquired immune deficiency syndromes (1999) 2003;33(4):536-42.
2003: Marco Salemi; Tulio De Oliveira; Valerie Courgnaud; Vincent Moulton; Barbara Holland; Sharon Cassol; William Switzer; Anne-Mieke Vandamme
Mosaic genomes of the six major primate lentivirus lineages revealed by phylogenetic analyses.
Journal of virology 2003;77(13):7202-13.
2003: Terezinha de Jesus Teixeira Santos; Carlos Maurício de Castro Costa; Patrick Goubau; Anne-Mieke Vandamme; Jan Desmyter; Sonia Van Doren; Rosa Maria Salani Mota; Francine Bovy de Castro Costa; Ana C S Oliveira; Vania Barreto; A F Gomes; Anna B Carneiro-Proietti; Veralice M S de Bruin; Francisca Cléa Florenço De Sousa; Reinaldo Oria
Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2003;7(3):202-9.
2003: Luiz C J Alcantara; Nice Shindo; Sonia Van Dooren; Marco Salemi; Maria Cecília Costa; Simone Kashima; Dimas Tadeu Covas; Anne-Mieke Vandamme; Bernardo Galvão-Castro
Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs.
AIDS research and human retroviruses 2003;19(6):519-23.
2003: C Sanchez-Palacios; E Gotuzzo; Anne-Mieke Vandamme; Y Maldonado
Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2003;7(2):132-7.
2003: Kenneth E Robbins; Philippe Lemey; Oliver G Pybus; Harold W Jaffe; Ae Youngpairoj; Teresa M Brown; Marco Salemi; Anne-Mieke Vandamme; Marcia L Kalish
U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains.
Journal of virology 2003;77(11):6359-66.
2003: Philippe Lemey; Oliver G Pybus; Bin Wang; Nitin K Saksena; Marco Salemi; Anne-Mieke Vandamme
Tracing the origin and history of the HIV-2 epidemic.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6588-92.
2003: Laurence Vergne; Dimitrios Paraskevis; Anne-Mieke Vandamme; Eric Delaporte; Martine Peeters
High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid.
AIDS (London, England) 2003;17(7):1105-7.
2003: Jaideep Ravela; Bradley J Betts; Françoise Brun-Vézinet; Anne-Mieke Vandamme; Diane Descamps; Kristel van Laethem; Kate Smith; Jonathan M Schapiro; Dean L Winslow; Caroline Reid; Robert W Shafer
HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.
Journal of acquired immune deficiency syndromes (1999) 2003;33(1):8-14.
2003: Nathalie Charlier; Richard Molenkamp; Pieter Leyssen; Anne-Mieke Vandamme; Erik De Clercq; Peter J Bredenbeek; Johan Neyts
A rapid and convenient variant of fusion-PCR to construct chimeric flaviviruses.
Journal of virological methods 2003;108(1):67-74.
2002: Valery Fikkert; Peter Cherepanov; Kristel Van Laethem; Anke Hantson; Barbara Van Remoortel; Christophe Pannecouque; Erik De Clercq; zeger debyser; Anne-Mieke Vandamme; Myriam Witvrouw
env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors.
Antimicrobial agents and chemotherapy 2002;46(12):3954-62.
2002: Dirk Daelemans; Elena Afonina; Jakob Nilsson; Gudrun Werner; Jørgen Kjems; Erik De Clercq; George Pavlakis; Anne-Mieke Vandamme
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(22):14440-5.
2002: Margaret Duffy; Marco Salemi; Noreen Sheehy; Anne-Mieke Vandamme; John E Hegarty; Michael Curry; Niamh Nolan; Dermot Kelleher; Susan M McKiernan; William W Hall
Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection.
Virology 2002;301(2):354-64.
2002: Valerie Courgnaud; Marco Salemi; Xavier Pourrut; Eitel Mpoudi-Ngole; Bernadette Abela; Philippe Auzel; Frederic Bibollet-Ruche; Beatrice Hahn; Anne-Mieke Vandamme; Eric Delaporte; Martine Peeters
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny.
Journal of virology 2002;76(16):8298-309.
2002: Nathalie Charlier; Pieter Leyssen; Cornelis W A Pleij; Philippe Lemey; Frédérique Billoir; Kristel Van Laethem; Anne-Mieke Vandamme; Erik De Clercq; Xavier de Lamballerie; Johan Neyts
Complete genome sequence of Montana Myotis leukoencephalitis virus, phylogenetic analysis and comparative study of the 3' untranslated region of flaviviruses with no known vector.
The Journal of general virology 2002;83(Pt 8):1875-85.
2002: Koen A De Smet; Sabina De Geest; Inge Derdelinckx; Herman Bobbaers; An Carbonez; Ann E Deschamps; Veerle De Graeve; Veerle De Saar; Helga Ceunen; Koen De Smet; Bart Maes; Willy E Peetermans; Yoeri Schrooten; Jan Desmyter; Erik De Clercq; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.
Antiviral chemistry & chemotherapy 2002;13(4):231-40.
2002: Shoukat H Qari; Mark Winters; Anne-Mieke Vandamme; Thomas C Merigan; Walid Heneine
A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Antiviral therapy 2002;7(2):131-9.
2002: Kristel Van Laethem; Andrea De Luca; Andrea Antinori; Antonella Cingolani; Carlo Federico Perna; Anne-Mieke Vandamme
A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.
Antiviral therapy 2002;7(2):123-9.
2002: Gkikas Magiorkinis; Dimitrios Paraskevis; Emmanouil Magiorkinis; Anne-Mieke Vandamme; Angelos Hatzakis
Reanalysis of the HIV-1 circulating recombinant form A/E (CRF01_AE): evidence of A/E/G recombination.
Journal of acquired immune deficiency syndromes (1999) 2002;30(1):124-9.
2002: Joke Snoeck; Sonia Van Dooren; Kristel Van Laethem; Inge Derdelinckx; Eric Van Wijngaerden; Erik De Clercq; Anne-Mieke Vandamme
Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999.
Virus research 2002;85(1):95-107.
2002: Philippe Lemey; Marco Salemi; Leda Bassit; Anne-Mieke Vandamme
Phylogenetic classification of TT virus groups based on the N22 region is unreliable.
Virus research 2002;85(1):47-59.
2002: Kristien Van Vaerenbergh; Thomas Harrer; Jean-Claude Schmit; An Carbonez; E Fontaine; M Kurowski; Mathias Grünke; Peter Löw; Astrid Rascu; Barbara Schmidt; Matthias Schmitt; Inge Thoelen; Hauke Walter; Kristel Van Laethem; Marc Van Ranst; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.
AIDS research and human retroviruses 2002;18(6):419-26.
2002: Martha J Lewis; Noreen Sheehy; Marco Salemi; Anne-Mieke Vandamme; William W Hall
Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
Virology 2002;295(1):182-9.
2002: Eric Van Wijngaerden; Veerle De Saar; Veerle De Graeve; Anne-Mieke Vandamme; Kristien Van Vaerenbergh; Herman Bobbaers; Ann E Deschamps; Helga Ceunen; Sabina De Geest
Nonadherence to highly active antiretroviral therapy: clinically relevant patient categorization based on electronic event monitoring.
AIDS research and human retroviruses 2002;18(5):327-30.
2002: Sonia Van Dooren; William Switzer; Walid Heneine; Patrick Goubau; Ernst J Verschoor; Bharat Parekh; Walter De Meurichy; Chris Furley; Marc Van Ranst; Anne-Mieke Vandamme
Lack of evidence for infection with simian immunodeficiency virus in bonobos.
AIDS research and human retroviruses 2002;18(3):213-6.
2002: Pieter Leyssen; Nathalie Charlier; Philippe Lemey; Frédérique Billoir; Anne-Mieke Vandamme; Erik De Clercq; Xavier de Lamballerie; Johan Neyts
Complete genome sequence, taxonomic assignment, and comparative analysis of the untranslated regions of the Modoc virus, a flavivirus with no known vector.
Virology 2002;293(1):125-40.
2002: Nice Shindo; Luiz C J Alcantara; Sonia Van Dooren; Marco Salemi; Maria Cecília Costa; Simone Kashima; Dimas Tadeu Covas; Antônio Teva; Marco Pellegrini; Ivo Brito; Anne-Mieke Vandamme; Bernardo Galvão-Castro
Human retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological study and molecular epidemiology of HTLV type 2 isolates.
AIDS research and human retroviruses 2002;18(1):71-7.
2002: Marco Salemi; Anne-Mieke Vandamme
Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences.
Journal of molecular evolution 2002;54(1):62-70.
2001: Sonia Van Dooren; Marco Salemi; Xavier Pourrut; Martine Peeters; Eric Delaporte; Marc Van Ranst; Anne-Mieke Vandamme
Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon.
Journal of virology 2001;75(23):11939-41.
2001: E Fontaine; C Riva; Martine Peeters; Jean-Claude Schmit; Eric Delaporte; Kristel Van Laethem; Kristien Van Vaerenbergh; Joke Snoeck; Eric Van Wijngaerden; Erik De Clercq; Marc Van Ranst; Anne-Mieke Vandamme
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J.
Journal of acquired immune deficiency syndromes (1999) 2001;28(3):254-8.
2001: Dimitrios Paraskevis; Emmanouil Magiorkinis; Gkikas Magiorkinis; Cleo G Anastassopoulou; Marios Lazanas; Georgios Chrysos; Anne-Mieke Vandamme; Angelos Hatzakis
Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype.
The Journal of general virology 2001;82(Pt 10):2509-14.
2001: Claudia Balotta; G Facchi; Michela Violin; S Van Dooren; Alessandro Cozzi-Lepri; Federica Forbici; Ada Bertoli; Chiara Riva; D Senese; P Caramello; Giuseppe Carnevale; Giuliano Rizzardini; L Cremonini; Laura Monno; Giovanni Rezza; Carlo Federico Perno; Giuseppe Ippolito; Antonella d'Arminio Monforte; Anne-Mieke Vandamme; Mauro Moroni
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.
Journal of acquired immune deficiency syndromes (1999) 2001;27(5):499-505.
2001: Dirk Daelemans; Erik De Clercq; Anne-Mieke Vandamme
A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors.
Journal of virological methods 2001;96(2):183-8.
2001: Sonia Van Dooren; Marco Salemi; Anne-Mieke Vandamme
Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes.
Molecular biology and evolution 2001;18(4):661-71.
2001: Kristel Van Laethem; Myriam Witvrouw; Christophe Pannecouque; Barbara Van Remoortel; Jean-Claude Schmit; Robert M Esnouf; JP Kleim; Jan Balzarini; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.
AIDS (London, England) 2001;15(5):553-61.
2001: Kristien Van Vaerenbergh; L Debaisieux; Nancy De Cabooter; C Declercq; Koenraad Desmet; Katrien Fransen; Bart Maes; Denise Marissens; K Miller; Gaëtan Muyldermans; S Sprecher; Lieven Stuyver; Dolores Vaira; Chris Verhofstede; Georges Zissis; Marc Van Ranst; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
Antiviral therapy 2001;6(1):63-70.
2001: Anne-Mieke Vandamme; F Houyez; D Bànhegyi; Bonaventura Clotet; G De Schrijver; Koen De Smet; W W Hall; R Harrigan; N Hellmann; Kurt Hertogs; C Holtzer; Brendan Larder; D Pillay; E Race; Jean-Claude Schmit; R Schuurman; E Schulse; Anders Sönnerborg; V Miller
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up.
Antiviral therapy 2001;6(1):21-39.
2001: Dimitrios Paraskevis; M Magiorkinis; Anne-Mieke Vandamme; Leondios G Kostrikis; Angelos Hatzakis
Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern.
The Journal of general virology 2001;82(Pt 3):575-80.
2001: H Pelemans; A Aertsen; Kristel Van Laethem; Anne-Mieke Vandamme; Erik De Clercq; María-Jesús Pérez-Pérez; Ana San-Félix; Sonsoles Velázquez; María-José Camarasa; Jan Balzarini
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Virology 2001;280(1):97-106.
2001: Marco Salemi; K Strimmer; William W Hall; Margaret Duffy; Eric Delaporte; S Mboup; Martine Peeters; Anne-Mieke Vandamme
Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(2):276-8.
2000: Anne-Mieke Vandamme; Umberto Bertazzoni; Marco Salemi
Evolutionary strategies of human T-cell lymphotropic virus type II.
Gene 2000;261(1):171-80.
2000: Barbara Schmidt; Hauke Walter; B Moschik; Christiane Paatz; Kristien Van Vaerenbergh; Anne-Mieke Vandamme; Matthias Schmitt; Thomas Harrer; Klaus Uberla; Klaus Korn
Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance.
AIDS (London, England) 2000;14(12):1731-8.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; J Albert; C A Boucher; Bonaventura Clotet; Marco Floridia; J Gerstoft; B Hejdeman; C Nielsen; Christophe Pannecouque; L Perrin; Maria F Pirillo; Lidia Ruiz; Jean-Claude Schmit; F Schneider; A Schoolmeester; R Schuurman; Hans-Jürgen Stellbrink; Lieven Stuyver; Jan van Lunzen; Barbara Van Remoortel; Eric Van Wijngaerden; STEFANO VELLA; Myriam Witvrouw; S Yerly; Erik De Clercq; J Destmyer; Anne-Mieke Vandamme
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Antimicrobial agents and chemotherapy 2000;44(8):2109-17.
2000: Kristel Van Laethem; Jean-Claude Schmit; H Pelemans; Jan Balzarini; Myriam Witvrouw; María-Jesús Pérez-Pérez; María-José Camarasa; Robert M Esnouf; Stefano Aquaro; Alessandra Cenci; Carlo Federico Perno; Philippe Hermans; S Sprecher; Lidia Ruiz; Bonaventura Clotet; Eric Van Wijngaerden; Marc Van Ranst; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.
AIDS research and human retroviruses 2000;16(9):825-33.
2000: Martha J Lewis; P Novoa; Ricardo Ishak; M O G Ishak; Marco Salemi; Anne-Mieke Vandamme; Mark H Kaplan; William W Hall
Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II).
Virology 2000;271(1):142-54.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; Eric Van Wijngaerden; Jean-Claude Schmit; F Schneider; Lidia Ruiz; Bonaventura Clotet; Chris Verhofstede; Filip Van Wanzeele; Gaëtan Muyldermans; P Simons; Lieven Stuyver; Philippe Hermans; C Evans; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.
AIDS research and human retroviruses 2000;16(6):529-37.
2000: Gaëtan Muyldermans; L Debaisieux; K Fransen; Denise Marissens; K Miller; D Vaira; Anne-Mieke Vandamme; A T Vandenbroucke; Chris Verhofstede; R Schuurman; Georges Zissis; Sabine Lauwers
Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):213-7.
2000: Kristel Van Laethem; Myriam Witvrouw; Jan Balzarini; Jean-Claude Schmit; S Sprecher; Philippe Hermans; M Leal; Thomas Harrer; Lidia Ruiz; Bonaventura Clotet; Marc Van Ranst; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
AIDS (London, England) 2000;14(4):469-71.
2000: Marco Salemi; Jan Desmyter; Anne-Mieke Vandamme
Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences.
Molecular biology and evolution 2000;17(3):374-86.
2000: Anne-Mieke Vandamme; W W Hall; M J Lewis; Patrick Goubau; M Salemi
Origins of HTLV-1 in South America.
Nature medicine 2000;6(3):232-3.
2000: Jean-Pierre Allain; Y Dong; Anne-Mieke Vandamme; Vincent Moulton; Marco Salemi
Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.
Journal of virology 2000;74(6):2541-9.
2000: Anne-Mieke Vandamme
The Fifth European Workshop on Virus Evolution and Molecular Epidemiology, Leuven, Belgium, 30 August to 4 September 1999. Evolving viruses and virologists.
Trends in microbiology 2000;8(1):8-10.
2000: Dirk Daelemans; Dominique Schols; Myriam Witvrouw; Christophe Pannecouque; Sigrid Hatse; Sonia Van Dooren; François Hamy; Thomas Klimkait; Erik De Clercq; Anne-Mieke Vandamme
A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
Molecular pharmacology 2000;57(1):116-24.
1999: Marco Salemi; M Lewis; J F Egan; William W Hall; Jan Desmyter; Anne-Mieke Vandamme
Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13253-8.
1999: Kristel Van Laethem; Koen A De Smet; Jean-Claude Schmit; S Sprecher; Philippe Hermans; V De Vroey; R Schuurman; Thomas Harrer; Myriam Witvrouw; Eric Van Wijngaerden; Lieven Stuyver; Marc Van Ranst; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations.
Journal of acquired immune deficiency syndromes (1999) 1999;22(2):107-18.
1999: Myriam Witvrouw; C Pannecouque; Kristel Van Laethem; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV.
AIDS (London, England) 1999;13(12):1477-83.
1999: Michel van Brussel; Marco Salemi; HF Liu; Patrick Goubau; Jan Desmyter; Anne-Mieke Vandamme
The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs.
Reviews in medical virology 1999;9(3):155-70.
1999: Marco Salemi; Anne-Mieke Vandamme; Jan Desmyter; Claudio Casoli; Umberto Bertazzoni
The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy.
Gene 1999;234(1):11-21.
1999: Hauke Walter; Barbara Schmidt; Klaus Korn; Anne-Mieke Vandamme; Thomas Harrer; Klaus Uberla
Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;13(1-2):71-80.
1999: Anne-Mieke Vandamme; Kristel Van Laethem; Jean-Claude Schmit; Eric Van Wijngaerden; M Reynders; zeger debyser; Myriam Witvrouw; Marc Van Ranst; Erik De Clercq; Jan Desmyter
Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood.
European journal of clinical investigation 1999;29(5):445-52.
1999: Robert Oelrichs; Anne-Mieke Vandamme; K Van Laethem; zeger debyser; Francine E McCutchan; Nicholas J Deacon
Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa.
AIDS research and human retroviruses 1999;15(6):585-9.
1999: Anne-Mieke Vandamme; K Van Laethem; Erik De Clercq
Managing resistance to anti-HIV drugs: an important consideration for effective disease management.
Drugs 1999;57(3):337-61.
1999: Michel van Brussel; Anne-Mieke Vandamme
[Growing divergence inside primate T cell lymphotropic viruses].
Verhandelingen - Koninklijke Academie voor Geneeskunde van België 1999;61(1):39-63.
1999: Dirk Daelemans; Anne-Mieke Vandamme; Erik De Clercq
Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.
Antiviral chemistry & chemotherapy 1999;10(1):1-14.
1998: Anne-Mieke Vandamme; Marco Salemi; Jan Desmyter
The simian origins of the pathogenic human T-cell lymphotropic virus type I.
Trends in microbiology 1998;6(12):477-83.
1998: Sonia Van Dooren; Eduardo Gotuzzo; Marco Salemi; D Watts; E Audenaert; S Duwe; Heinz Ellerbrok; R Grassmann; E Hagelberg; Jan Desmyter; Anne-Mieke Vandamme
Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America.
The Journal of general virology 1998;79 ( Pt 11)():2695-708.
1998: Jean-Claude Schmit; Kristel Van Laethem; Lidia Ruiz; Philippe Hermans; S Sprecher; Anders Sönnerborg; M Leal; Thomas Harrer; Bonaventura Clotet; Vic Arendt; E Lissen; Myriam Witvrouw; Jan Desmyter; Erik De Clercq; Anne-Mieke Vandamme
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries.
AIDS (London, England) 1998;12(15):2007-15.
1998: Myriam Witvrouw; Dirk Daelemans; Christophe Pannecouque; Johan Neyts; Graciela Andrei; Robert Snoeck; Anne-Mieke Vandamme; Jan Balzarini; Jan Desmyter; M Baba; Erik De Clercq
Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
Antiviral chemistry & chemotherapy 1998;9(5):403-11.
1998: Heinz Ellerbrok; Carola Fleischer; Marco Salemi; P Reinhardt; W D Ludwig; Anne-Mieke Vandamme; Georg Pauli
Sequence analysis of the first HTLV-I infection in Germany without relations to endemic areas.
AIDS research and human retroviruses 1998;14(13):1199-203.
1998: Marco Salemi; Sonia Van Dooren; E Audenaert; Eric Delaporte; Patrick Goubau; Jan Desmyter; Anne-Mieke Vandamme
Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains.
Virology 1998;246(2):277-87.
1998: Jean-Claude Schmit; Lidia Ruiz; Lieven Stuyver; Kristel Van Laethem; I Vanderlinden; T Puig; Rudi Rossau; Jan Desmyter; Erik De Clercq; Bonaventura Clotet; Anne-Mieke Vandamme
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.
Journal of virological methods 1998;73(1):77-82.
1998: H Pelemans; Robert M Esnouf; Michael A Parniak; Anne-Mieke Vandamme; Erik De Clercq; Jan Balzarini
A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.
The Journal of general virology 1998;79 ( Pt 6)():1347-52.
1998: Anne-Mieke Vandamme; Kristien Van Vaerenbergh; Erik De Clercq
Anti-human immunodeficiency virus drug combination strategies.
Antiviral chemistry & chemotherapy 1998;9(3):187-203.
1998: Anne-Mieke Vandamme; Marco Salemi; Michel van Brussel; HF Liu; Kristel Van Laethem; Marc Van Ranst; L Michels; Jan Desmyter; Patrick Goubau
African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.
Journal of virology 1998;72(5):4327-40.
1998: Marco Salemi; Anne-Mieke Vandamme; C Gradozzi; Kristel Van Laethem; E Cattaneo; G Taylor; Claudio Casoli; Patrick Goubau; Jan Desmyter; Umberto Bertazzoni
Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users.
Journal of molecular evolution 1998;46(5):602-11.
1998: Michel van Brussel; Marco Salemi; HF Liu; Jan Gabriels; Patrick Goubau; Jan Desmyter; Anne-Mieke Vandamme
The simian T-lymphotropic virus STLV-PP1664 from Pan paniscus is distinctly related to HTLV-2 but differs in genomic organization.
Virology 1998;243(2):366-79.
1998: zeger debyser; Eric Van Wijngaerden; Kristel Van Laethem; Kurt Beuselinck; M Reynders; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain.
AIDS research and human retroviruses 1998;14(5):453-9.
1998: Myriam Witvrouw; M E Arranz; Christophe Pannecouque; Ruben Declercq; H Jonckheere; Jean-Claude Schmit; Anne-Mieke Vandamme; J A Diaz; ST Ingate; Jan Desmyter; Robert M Esnouf; Luc Van Meervelt; S Vega; Jan Balzarini; Erik De Clercq
1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.
Antimicrobial agents and chemotherapy 1998;42(3):618-23.
1998: Kristel Van Laethem; Kurt Beuselinck; Sonia Van Dooren; Erik De Clercq; Jan Desmyter; Anne-Mieke Vandamme
Diagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical origin.
Journal of virological methods 1998;70(2):153-66.
1998: Dirk Daelemans; Anne-Mieke Vandamme; S Shuto; A Matsuda; Erik De Clercq
Stereospecificity of 6'-C-neplanocin A analogues as inhibitors of S-adenosylhomocysteine hydrolase activity and human immunodeficiency virus replication.
Nucleosides & nucleotides 1998;17(1-3):479-86.
1997: Dirk Daelemans; José A Esté; Myriam Witvrouw; Christophe Pannecouque; H Jonckheere; Stefano Aquaro; Carlo Federico Perno; Erik De Clercq; Anne-Mieke Vandamme
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
Molecular pharmacology 1997;52(6):1157-63.
1997: HF Liu; Patrick Goubau; Michel van Brussel; Jan Desmyter; Anne-Mieke Vandamme
Phylogenetic analysis of a simian T lymphotropic virus type I from a hamadryas baboon.
AIDS research and human retroviruses 1997;13(17):1545-8.
1997: H Pelemans; Robert M Esnouf; A Dunkler; Michael A Parniak; Anne-Mieke Vandamme; Anna Karlsson; Erik De Clercq; JP Kleim; Jan Balzarini
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.
Journal of virology 1997;71(11):8195-203.
1997: Heinz Ellerbrok; Carola Fleischer; Anne-Mieke Vandamme; Claudia Kücherer; Georg Pauli
Sequence analysis of two HTLV type I infections imported to Germany.
AIDS research and human retroviruses 1997;13(14):1255-8.
1997: J A Este; Dominique Schols; K De Vreese; Kristel Van Laethem; Anne-Mieke Vandamme; Jan Desmyter; Erik De Clercq
Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.
Molecular pharmacology 1997;52(1):98-104.
1997: M Van Brüssel; Patrick Goubau; R Rousseau; Jan Desmyter; Anne-Mieke Vandamme
Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat.
Journal of virology 1997;71(7):5464-72.
1997: Anne-Mieke Vandamme; Kristel Van Laethem; HF Liu; Michel van Brussel; Eric Delaporte; C M de Castro Costa; C Fleischer; G Taylor; Umberto Bertazzoni; Jan Desmyter; Patrick Goubau
Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.
Journal of medical virology 1997;52(1):1-7.
1997: Nitin K Saksena; A Srinivasan; Ying C Ge; SH Xiang; A Azad; WV Bolton; V Herve; S Reddy; Ousmane M Diop; Monica Miranda-Saksena; W D Rawlinson; Anne-Mieke Vandamme; F Barre-Sinoussi
Simian T cell leukemia virus type I from naturally infected feral monkeys from central and west Africa encodes a 91-amino acid p12 (ORF-I) protein as opposed to a 99-amino acid protein encoded by HTLV type I from humans.
AIDS research and human retroviruses 1997;13(5):425-32.
1997: Myriam Witvrouw; Jan Balzarini; Christophe Pannecouque; S Jhaumeer-Laulloo; José A Esté; Dominique Schols; Peter Cherepanov; Jean-Claude Schmit; zeger debyser; Anne-Mieke Vandamme; Jan Desmyter; S R Ramadas; Erik De Clercq
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.
Antimicrobial agents and chemotherapy 1997;41(2):262-8.
1997: Myriam Witvrouw; Jean-Claude Schmit; Barbara Van Remoortel; Dirk Daelemans; José A Esté; Anne-Mieke Vandamme; Jan Desmyter; Erik De Clercq
Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
AIDS research and human retroviruses 1997;13(2):187-92.
1996: Anne-Mieke Vandamme
BaEV is a relic from an ancient retrovirus that crossed species barriers.
Trends in microbiology 1996;4(12):478.
1996: Lidia Ruiz; Joan Romeu; Javier Martínez-Picado; Jean-Claude Schmit; Anne-Mieke Vandamme; Montserrat Balagué; C Cabrera; T Puig; Cristina Tural; A Segura; Guillem Sirera; E De Clercq; Bonaventura Clotet
Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC.
AIDS (London, England) 1996;10(14):F61-6.
1996: Jean-Claude Schmit; J Cogniaux; P Hermans; Christophe Van Vaeck; S Sprecher; B Van Remoortel; Myriam Witvrouw; Jan Balzarini; Jan Desmyter; E De Clercq; Anne-Mieke Vandamme
Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain.
The Journal of infectious diseases 1996;174(5):962-8.
1996: Anne-Mieke Vandamme; Jean-Claude Schmit; Sonia Van Dooren; Kristel Van Laethem; E Gobbers; W Kok; Patrick Goubau; Myriam Witvrouw; W Peetermans; E De Clercq; Jan Desmyter
Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(2):127-39.
1996: Jean-Claude Schmit; Lidia Ruiz; Bonaventura Clotet; A Raventos; J Tor; J Leonard; Jan Desmyter; E De Clercq; Anne-Mieke Vandamme
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538).
AIDS (London, England) 1996;10(9):995-9.
1996: Marco Salemi; Anne-Mieke Vandamme; F Guano; C Gradozzi; E Cattaneo; Claudio Casoli; Umberto Bertazzoni
Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of South European epidemics.
The Journal of general virology 1996;77 ( Pt 6)():1193-201.
1996: Patrick Goubau; Anne-Mieke Vandamme; Kurt Beuselinck; Jan Desmyter
Proviral HTLV-I and HTLV-II in the Efe pygmies of northeastern Zaire.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(2):208-9.
1996: Anne-Mieke Vandamme; HF Liu; Michel van Brussel; W De Meurichy; Jan Desmyter; Patrick Goubau
The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses.
The Journal of general virology 1996;77 ( Pt 5)():1089-99.
1996: José A Esté; K De Vreese; Myriam Witvrouw; Jean-Claude Schmit; Anne-Mieke Vandamme; Jozef Anne; Jan Desmyter; Geoffrey Henson; Gary J Bridger; E De Clercq
Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1.
Antiviral research 1996;29(2-3):297-307.
1996: HF Liu; Patrick Goubau; Michel van Brussel; Kristel Van Laethem; Y C Chen; Jan Desmyter; Anne-Mieke Vandamme
The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs.
The Journal of general virology 1996;77 ( Pt 2 )():359-68.
1996: Michel van Brussel; Patrick Goubau; R Rousseau; Jan Desmyter; Anne-Mieke Vandamme
The genomic structure of a new simian T-lymphotropic virus, STLV-PH969, differs from that of human T-lymphotropic virus types I and II.
The Journal of general virology 1996;77 ( Pt 2 )():347-58.
1996: Patrick Goubau; Anne-Mieke Vandamme; Jan Desmyter
Questions on the evolution of primate T-lymphotropic viruses raised by molecular and epidemiological studies of divergent strains.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13 Suppl 1():S242-7.
1995: José A Esté; Myriam Witvrouw; J Tu; Jan Desmyter; E De Clercq; Anne-Mieke Vandamme
Inhibition of HIV type 1 Tat-mediated trans-activation by oncostatin M in HLtat cells.
AIDS research and human retroviruses 1995;11(11):1355-8.
1995: Anne-Mieke Vandamme; Sonia Van Dooren; W Kok; Patrick Goubau; Katrien Fransen; T Kievits; Jean-Claude Schmit; E De Clercq; Jan Desmyter
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.
Journal of virological methods 1995;52(1-2):121-32.
1995: Carlos Maurício de Castro Costa; Patrick Goubau; HF Liu; Anne-Mieke Vandamme; F M da Cunha; TJ Santos; Jan Desmyter; Herwig Carton
HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern Brazil.
AIDS research and human retroviruses 1995;11(2):315-8.
1995: Anne-Mieke Vandamme; Katrien Fransen; L Debaisieux; D Marissens; S Sprecher; D Vaira; A T Vandenbroucke; Chris Verhofstede
Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories.
Journal of virological methods 1995;51(2-3):305-16.
1994: HF Liu; Anne-Mieke Vandamme; K Kazadi; Herwig Carton; Jan Desmyter; Patrick Goubau
Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire.
AIDS research and human retroviruses 1994;10(9):1135-42.
1994: HF Liu; Anne-Mieke Vandamme; Michel van Brussel; Jan Desmyter; Patrick Goubau
New retroviruses in human and simian T-lymphotropic viruses.
Lancet 1994;344(8917):265-6.
1994: Anne-Mieke Vandamme; HF Liu; Patrick Goubau; Jan Desmyter
Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I.
Virology 1994;202(1):212-23.
1994: Patrick Goubau; Michel van Brussel; Anne-Mieke Vandamme; HF Liu; Jan Desmyter
A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas).
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2848-52.
1994: Anne-Mieke Vandamme
Polymerase chain reaction (PCR) as a diagnostic tool in HIV infection.
Verhandelingen - Koninklijke Academie voor Geneeskunde van België 1994;56(3):231-65.
1994: Anne-Mieke Vandamme; zeger debyser; Rudi Pauwels; K De Vreese; P Goubau; M Youle; B Gazzard; P A Stoffels; G F Cauwenbergh; J Anne
Characterization of HIV-1 strains isolated from patients treated with TIBO R82913.
AIDS research and human retroviruses 1994;10(1):39-46.
1993: Patrick Goubau; HF Liu; G G De Lange; Anne-Mieke Vandamme; Jan Desmyter
HTLV-II seroprevalence in pygmies across Africa since 1970.
AIDS research and human retroviruses 1993;9(8):709-13.
1993: Jan Balzarini; Anna Karlsson; Anne-Mieke Vandamme; María-Jesús Pérez-Pérez; Hong Zhang; Lotta Vrang; B Oberg; Kristina Bäckbro; Torsten Unge; Ana San-Félix
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(15):6952-6.
1993: Rudi Pauwels; Koen Andries; zeger debyser; P Van Daele; Dominique Schols; P Stoffels; K De Vreese; R Woestenborghs; Anne-Mieke Vandamme; C G Janssen
Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(5):1711-5.
1993: Jan Balzarini; Anna Karlsson; María-Jesús Pérez-Pérez; Lotta Vrang; J Walbers; Hong Zhang; B Oberg; Anne-Mieke Vandamme; María-José Camarasa; E De Clercq
HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase.
Virology 1993;192(1):246-53.
1992: Myriam Witvrouw; Rudi Pauwels; Anne-Mieke Vandamme; Dominique Schols; D Reymen; N Yamamoto; Jan Desmyter; E De Clercq
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.
Antimicrobial agents and chemotherapy 1992;36(12):2628-33.
1992: Mieke Dewerchin; Anne-Mieke Vandamme; Paul Holvoet; F De Cock; Griet Lemmens; H Roger Lijnen; Jean Marie Stassen; Désiré Collen
Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
Thrombosis and haemostasis 1992;68(2):170-9.
1992: zeger debyser; Anne-Mieke Vandamme; Rudi Pauwels; M Baba; Jan Desmyter; E De Clercq
Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
The Journal of biological chemistry 1992;267(17):11769-76.
1992: K de Vreese; zeger debyser; Anne-Mieke Vandamme; Rudi Pauwels; Jan Desmyter; E de Clercq; Jozef Anne
Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
Virology 1992;188(2):900-4.
1992: Jan Balzarini; María-Jesús Pérez-Pérez; Ana San-Félix; Dominique Schols; Carlo Federico Perno; Anne-Mieke Vandamme; María-José Camarasa; E De Clercq
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(10):4392-6.
1992: Anne-Mieke Vandamme; Mieke Dewerchin; H Roger Lijnen; H Bernar; F Bulens; Luc Nelles; Désiré Collen
Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
European journal of biochemistry / FEBS 1992;205(1):139-46.
1991: F Bulens; Anne-Mieke Vandamme; H Bernar; Luc Nelles; Roger Lijnen; Désiré Collen
Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
European journal of biochemistry / FEBS 1991;195(1):235-42.
1990: Anne-Mieke Vandamme; F Bulens; H Bernar; Luc Nelles; Roger Lijnen; Désiré Collen
Construction and characterization of a recombinant murine monoclonal antibody directed against human fibrin fragment-D dimer.
European journal of biochemistry / FEBS 1990;192(3):767-75.
1990: Désiré Collen; H Roger Lijnen; F Bulens; Anne-Mieke Vandamme; A Tulinsky; Luc Nelles
Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.
The Journal of biological chemistry 1990;265(21):12184-91.
1987: Anne-Mieke Vandamme; Gisèle Préaux; R Lontie
Isolation of mRNA from membrane-bound polysomes synthesizing Sepia officinalis haemocyanin in Xenopus laevis oocytes.
Biochemistry international 1987;14(1):27-35.